Why Stimulants Are Used for ADHD
Stimulants are used for ADHD because they have the strongest evidence base of any psychiatric medication, with 65-75% of patients showing improvement compared to only 5-30% on placebo, representing the largest body of treatment literature for any childhood-onset psychiatric disorder. 1
Mechanism of Action
Stimulants work by increasing dopamine and norepinephrine neurotransmission in the prefrontal cortex, the brain region responsible for executive functions like impulse control, planning, and working memory—all of which are impaired in ADHD 2, 3. Specifically:
- Methylphenidate blocks the reuptake of dopamine and norepinephrine at the dopamine transporter in the striatum
- Amphetamines increase presynaptic release of these neurotransmitters
- Both mechanisms enhance catecholaminergic signaling in the prefrontal cortex, directly addressing the core pathophysiology of ADHD 1, 4, 5
Clinical Evidence Supporting Stimulant Use
The evidence supporting stimulants is unparalleled:
- 161 randomized controlled trials published by 1996, encompassing 5,899 patients across all age groups 1
- Effect size of 1.0 for stimulants versus 0.7 for nonstimulants—this is a clinically meaningful difference 6
- The landmark MTA study demonstrated that stimulants (alone or with behavioral therapy) produce stable improvements in ADHD symptoms over 12-24 months of continuous treatment 1, 2
Specific Behavioral and Functional Improvements
Stimulants produce measurable improvements across multiple domains 1:
In the classroom:
- Decreased interrupting, fidgeting, and finger tapping
- Increased on-task behavior
At home:
- Improved parent-child interactions
- Better compliance with requests
- Enhanced on-task behaviors during homework
In social settings:
- Improved peer nomination rankings
- Increased attention during sports activities
Cognitive benefits:
- Decreased response variability and impulsive responding
- Increased accuracy of performance
- Improved short-term memory, reaction time, and math computation
- Enhanced sustained attention and problem-solving
Why Stimulants Over Other Options
Stimulants remain first-line treatment because approximately 40% of patients respond to both methylphenidate and amphetamine, while another 40% respond to only one—meaning 80% of patients will respond to stimulants if both are tried 6. This response rate far exceeds nonstimulants.
Attempts to treat ADHD through:
- Modulatory neurotransmitter systems
- Cognitive-enhancing drugs without catecholaminergic effects
- Triple reuptake inhibitors
All have failed in clinical trials 2. This confirms that effective ADHD treatment requires direct or indirect enhancement of catecholaminergic neurotransmission in the prefrontal cortex.
Important Clinical Considerations
Comorbidities are not contraindications: Stimulants continue to ameliorate ADHD symptoms even in the presence of comorbid anxiety disorders, oppositional defiant disorder, conduct disorder, and learning disorders—and may even improve the comorbid condition 1
Individual response is idiosyncratic: The subtype of ADHD (inattentive, hyperactive, or combined) does not predict which specific stimulant will work best 6. If one stimulant fails, try the other class before abandoning stimulant therapy.
Duration of action matters: Immediate-release formulations provide only 3-5 hours of benefit, requiring multiple daily doses 1. Modern extended-release formulations improve compliance and reduce diversion risk 2.
Common Pitfalls to Avoid
- Don't assume stimulants won't work in anxious patients—ADHD with separation anxiety disorder, generalized anxiety disorder, or social phobia can be treated with stimulants 1
- Don't stop at inadequate doses—the MTA study used doses up to 50 mg/day of methylphenidate 1
- Don't give up after one stimulant fails—try the other class (methylphenidate vs. amphetamine) before switching to nonstimulants 6